Recombinant interferon-alpha therapy and meno-metrorrhagia

Br J Obstet Gynaecol. 1998 Mar;105(3):367-8. doi: 10.1111/j.1471-0528.1998.tb10104.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiviral Agents / adverse effects*
  • Female
  • Hepatitis C / therapy
  • Humans
  • Interferon Type I / adverse effects*
  • Metrorrhagia / etiology*
  • Recombinant Proteins

Substances

  • Antiviral Agents
  • Interferon Type I
  • Recombinant Proteins